FDA Advisory Panel Vetoes Wuhan Virus Vaccine Booster Shots for Most Americans

AP Photo/Virginia Mayo

It is no secret that the centerpiece of the strategy managed by Joe Biden’s cronies of using the Wuhan virus “pandemic” to destroy what has been normal for some 250 years and broadly reshape American society into one devoid of individual rights is the vaccine. Even though the evidence available to our lying eyes…a wildly increasing number of cases even in places with a high vaccination rate and significant “breakthrough” infections that strike down fully vaccinated persons…the White House is adopting punitive measures to coerce the recalcitrant.


Not satisfied with one round of coerced vaccinations, the White House was trying, with the assistance of Pharma lobbyists, to require a booster shot. To get there they needed FDA approval, and the White House was so sure of its power that it announced that boosters would be available to all Americans beginning Monday, September 20.

Here is Joe SoftServe on September 9, announcing, in his best tongue-tied, brain embolism way, that if two shots were good, then three had to be a damned sight better, and you’d be getting your third as soon as some frivolous paperwork was taken care of.


The FDA met today to consider the proposal to start what amounts to a nationwide Phase III Clinical Trial of an untested booster shot. Unfortunately for Biden and luckily for us, things quickly went off the rails.

A Food and Drug Administration advisory panel endorsed booster shots of the Covid-19 vaccine from Pfizer and BioNTech SE for adults older than 65 years and those at high risk of severe disease, bringing the Biden administration one step closer to starting a booster campaign for millions of Americans.

The outside panel on Friday voted 16-2 against advising the FDA to approve a booster dose of the vaccine at least six months after the second shot for people 16 years and older.

The vote followed a daylong meeting that included intense debate among committee members over who should receive boosters and when, and presentations that offered varying conclusions about declining vaccine effectiveness and the benefit of administering extra shots.

Many panel members said they had concerns about widening booster shots for the general population with limited data about whether the additional doses would be safe and effective. Members said they would potentially support recommending a third dose for certain high-risk groups of the population such as older adults but that there wasn’t enough data to justify giving it to the general population. They said that vaccines such as Pfizer’s are holding up against severe disease.

“The marginal benefit of a third dose of vaccine for people who are already vaccinated is likely to be very small for reducing the overall burden,” said Eric Rubin, a Harvard microbiologist, panel member and editor in chief of the New England Journal of Medicine.


There were hints earlier in the month that responsible medical professionals were coming to the conclusion that the Biden bunch was using a generated panic to play fast and loose with the health of Americans. Late last month, two senior FDA officials resigned in protest over the rushed deployment of untested booster shots for the entire country:

On Tuesday, two top FDA vaccine regulators resigned — a decision that one former official said was rooted in anger over the agency’s lack of autonomy in the booster planning so far. A current health official said the pair, Marion Gruber and Philip Krause, left over differences with FDA’s top vaccine official Peter Marks. Now the agency is facing a potential mutiny among its staff and outside vaccine advisers, several of whom feel cut out of key decisions and who view the plan to offer boosters to all adults as premature and unnecessary.

POLITICO spoke to 11 current and former health officials and people familiar with the matter who described growing exasperation with the administration’s disjointed process for implementing its booster plan. Those sources said there is little coordination between federal health agencies, even as two top FDA officials try to guide the rollout.

On the eve of the vote, 18 prominent vaccine scientists, including the two FDA staffers who resigned, signed a public letter saying boosters-for-all was a risky and unnecessary strategy.

Eighteen top scientists from across the world have warned against giving COVID-19 booster shots to most fully vaccinated people.

In an review published in the Lancet on Monday, the experts said that the idea of boosting immunity to reduce COVID-19 cases was “appealing.” But current evidence didn’t support “widespread use of booster vaccination” in the general population, they said, citing 93 references.

“Careful and public scrutiny of the evolving data will be needed to assure that decisions about boosting are informed by reliable science more than by politics,” the review authors said.


You can’t overstate the seriousness of this vote. No amount of spin on what the FDA panel approved can offset what it resoundingly said it would not support. This is literally the first time anyone on the health care side of the equation has said, ¡No más! And they said it even though the White House had already set a roll-out date for Monday, and by scheduling this vote for a Friday, they clearly considered it pro forma action. So Jordan Schachtel is entirely correct (if you aren’t following his Substack, you should).

This slap-down was an open rebellion against the White House’s vaccination express train.

The FDA, of course, is not legally bound by the advisory board decision. They could order the roll-out to proceed on schedule. But the political risk of such an act would risk a backlash that the Biden bunch doesn’t want. I expect the Biden White House to regroup, wait for a brief interval, and resubmit the application. That has its own risk because a second veto would be tantamount to demolishing the Biden/Pharma effort to pump us all full of vaccines for fun and profit.


Join the conversation as a VIP Member

Trending on RedState Videos